Refine Search
(122)
(200)
(508)
(530)

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

  • $2,500
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • $2,500
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H2 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Breast Cancer - Pipeline Review, H2 2016

  • $2,500
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H2 2016’, provides an overview of the Breast Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Breast Cancer, com...

Liver Cancer - Pipeline Review, H2 2016

  • $2,500
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H2 2016’, provides an overview of the Liver Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Liver Cancer, comple...

Parkinson's Disease - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2018’, provides an overview of the Parkinson's Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for...

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018’, provides an overview of the Human Immunodeficiency Virus (HIV) Infections (AIDS) pipeline landscape.

The report provides comprehen...

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under dev...

Non-Hodgkin Lymphoma - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2018’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Non-...

Multiple Sclerosis - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2018’, provides an overview of the Multiple Sclerosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Multiple...

Rheumatoid Arthritis - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2018’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rheu...

Ovarian Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2018’, provides an overview of the Ovarian Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, ...

Prostate Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2018’, provides an overview of the Prostate Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Prostate Cance...

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

The report p...

Colon Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2018’, provides an overview of the Colon Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colon Cancer, comple...